Login | SITEMAP | FAQS

Science & Society | News

ICVS Researchers Discover New Therapy

A team of researchers from the University of Minho’s ICVS discovered a new therapy that allows to reverse spinal cord injuries. The therapeutic approach that combines stem cells and biomaterials was already tested in animals. Watch here the video from Porto Canal.

More Info

Agostinho Carvalho, do ICVS / Escola de Medicina UM, recebe 1 milhão de euros para investigar doenças pulmonares

Agostinho Carvalho, do Instituto de Investigação em Ciências da Vida e Saúde (ICVS) da Escola de Medicina da Universidade do Minho, foi distinguido com uma bolsa de um milhão de euros, no primeiro concurso da “Iniciativa Ibérica de Investigação e Inovação Biomédica, i4b”, promovido pela Fundação “la Caixa” a pela Fundação para a Ciência e a Tecnologia. O concurso teve 785 candidaturas e vinte ...

More Info

The best high school students at ICVS.

The best high school students fromBraga, Viana do Castelo and Vila Real visited different schools/labs of UMinholast week in the “Melhores alunos na UMinho” initiative. ICVS/School ofMedicine received 12 of these students, which participated in differentscientific activities, namely in the field of Microbiology, Neuroscienceand Microsurgery.  In this Porto Canalreport you can find statements by Carla Martins, pro-rector for theInternationalization of Education, Rui O ...

More Info

First National Survey on Haemophilia

Haemophilia is a rare genetic disorder that affects about 700 people in Portugal (World Federation of Haemophilia, Annual Report 2015). Researchers from ICVS and School of Medicine at University of Minho, in collaboration with the Centre of Haemophilia at Centro Hospitalar São João and the Portuguese Haemophilia Association, are conducting a National Survey aiming to analyze the sociodemographic, psychosocial and clinical characteristics of people with Haemophilia, with a particular fo ...

More Info

Globally prevalent mutations in Plasmodium falciparum modulate susceptibility to artemisinin-based combination therapies.

Main findings Artemisinin-based combination therapies (ACTs) have been highly effective in recent years in treating Plasmodium falciparum infections and reducing the global burden of malaria. The parasite transporter protein, P. falciparum multidrug resistance 1 protein (PfMDR1), has been long observed in molecular epidemiological studies to associate with altered parasite susceptibility to multiple ACT partner drugs. Leveraging recent advances in P. falciparum genome editing via the use of zi ...

More Info
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next

Copyright © 2012-2016 ICVS. All rights reserved.